2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Comparison of Pure Laparoscopic vs Open Living Donor Right Hepatectomy

B. Lee, Y. Choi, H. Han, Y. Yoon, J. Cho.
Comparison of Recipients with Early and Late Presenting Polyomavirus Nephropathy (PVN) with Regard to Histological Findings and Graft Survival: What is the Influence of CD4/CD8 Ratio on the Presenting Time of PVN

B. Ozdemir,¹ S. Ayva,¹ A. Terzi,¹ A. Ok Atilgan,¹ E. Akcay,¹ E. Ayvazoglu Soy,² F. Ozdemir,³ M. Haberal.²
Comparison of Temperatures for Optimal Preservation of Donor Kidneys during Oxygenated Pulsatile Perfusion

R. Bhattacharjee,¹ M. Richard-Mohamed,² A. Ruthirakanthan,³ R. Mayer,² S. Luke,³ H. Sharma,² M. TunAbraham,² B. Alharbi,² A. Haig,² P. Luke.^1,2,3
Comparison of Three Approaches for Laparoscopic Donor Nephrectomy: Transvaginal, Transumbilical Single Site and Retroperitoneal

M. Miura, H. Higashiyama.
Comparison of Tobacco Consumption versus Marijuana Consumption in Liver Transplant Recipients

P. Serrano Rodriguez, R. Watkins, L. Jurgevich, D. Gerber, A. Nayyar, J. Jadi, C. Moses, C. Desai.
Compatible Donor and Recipient Pairs' Perspectives on Participation in Kidney Paired Donation Programs: The Emotional Implications of Indirect Donation and Transplantation

M. Fortin,¹ J. Gill,² F. Ballesteros,¹ J. Gill.²
Competing Risk Analysis in Renal Allograft Survival: A New Perspective to an Old Problem

M. El ters,¹ B. Smith,² F. Cosio,¹ W. Kremers.²
Complement Activating HLA Class 2 Antibodies Are Associated with Poor Renal Allograft Survival; Multicentre Study

A. Babu,^1,2 O. Shaw,⁵ N. Khovanova,² S. Griffin,⁴ D. Briggs,⁶ N. Krishnan,¹ S. Fletcher,¹ C. Imray,¹ A. Seitz,³ R. Baker,³ M. Wellberry-Smith,³ B. Clarke,³ K. Cullen,³ F. Edwards,⁴ T. Rees,⁴ E. Burrows,⁴ L. Howe,⁵ R. Vaughan,⁵ N. Kessaris,⁷ N. Mamode,⁷ A. Dorling,⁷ D. Zehnder,¹ R. Higgins,^1,2 D. Mitchell,² S. Daga.^2,3
Complement Fixing Donor-Specific Antibodies Are Associated with Increased Risk of Chronic Lung Allograft Dysfunction after Lung Transplantation

C. Ensor,¹ C. Iasella,¹ M. Mangiola,¹ M. Marrari,¹ M. Morrell,¹ N. Shigemura,² J. DCunha,¹ J. McDyer,¹ A. Zeevi.¹
Complex Combined Thoracic/liver Transplant: A Seven Year Experience

N. Presser, J. DiNorcia, V. Agopian, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z